H&H International Holdings (01112) saw its shares climb more than 5% during the trading session. At the time of writing, the stock was up 4.16%, trading at HK$12.53, with a turnover of HK$22.4759 million.

On March 24, H&H International Holdings released its annual results for the period ending December 31, 2025. The group reported revenue of RMB 14.354 billion, a 10% increase compared to the previous year. Profit attributable to owners of the parent company was RMB 196 million, marking a turnaround from a loss to a profit year-on-year. Basic earnings per share stood at RMB 0.31. The company proposed a final dividend of HK$0.16 per share. For the full year 2025, the group's total revenue grew by 10.3% on a like-for-like basis. The group maintained stable profitability, with an adjusted comparable EBITDA margin of 14.3%, while adjusted comparable net profit increased by 22.7%.

The company strengthened its market-leading position in adult nutrition and care products. After a decade of strategic governance, Swisse achieved a revenue milestone of US$1 billion in 2025. During the year, Swisse ranked first in the overall vitamin, herbal, and mineral supplement market in mainland China and also secured the top position in the Australian market. It achieved double-digit growth in both mainland China and its expansion markets.